Trial site
The Royal Surrey County Hospital NHS Foundation Trust
Guildford, GU2 7XX, United KingdomNot linked to an institution yet
The trials here
What the 9 trials at this site are about, from their registry records.
- Phase
- Phase 34 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Recruiting7 trials
- Active, not recruiting2 trials
- Lead sponsor
- Bristol-Myers Squibb4 trials
- Immutep S.A.S.1 trial
- Janssen Research & Development, LLC1 trial
- Johnson & Johnson Enterprise Innovation Inc.1 trial
- Royal Surrey County Hospital NHS Foundation Trust1 trial
- and 1 more
Running trials
Recruiting
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
NCT07680764· Phase 2· Bristol-Myers Squibb· Source
Contact: Ali Suwaidan, Site 0037
Recruiting
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
NCT07361497· Phase 3· Bristol-Myers Squibb· Source
Contact: Ajay Mehta, Site 0257
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
NCT07361510· Phase 3· Bristol-Myers Squibb· Source
Contact: Ajay Mehta, Site 0007
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
NCT07221357· Phase 2/3· Bristol-Myers Squibb· Source
Contact: Sophie Otter, Site 0644
Active, not recruiting
Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)
NCT06726265· Phase 3· Immutep S.A.S.· Source
Recruiting
MIRRORS-FROZEN - Comparing Open Vs Robotic Surgery in the Management of Women With Complex Pelvic Adnexal Masses ≤ 8cm.
NCT06638593· Royal Surrey County Hospital NHS Foundation Trust· Source
Contact: Radwa Hablase, MBBCh MRCOG PGCert
Recruiting
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
NCT06385080· Phase 1/2· Janssen Research & Development, LLC· Source
Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
NCT04892173· Phase 3· Johnson & Johnson Enterprise Innovation Inc.· Source
Active, not recruiting
IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients
NCT01398085· Phase 2/3· University College, London· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error